Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
Pancreatic most cancers, also known as a silent killer, is a most cancers that impacts hundreds of individuals around the globe. Elevating consciousness...
Throughout the CURE® Educated Affected person® Metastatic Breast Most cancers Summit, an professional spoke about what sufferers can count on earlier than enrolling...
